We are participating in the XVIII Congresso Nazionale SIES 2024 (Società Italiana di Ematologia Sperimentale), organized on 7-9 March 2024 in Florence, Italy.
HARMONY Partner Luca Guarnera of PTV-Policlinico Tor Vergata di Roma will present the results of the APL project: "LONG-TERM OUTCOME OF A LARGE COHORT OF PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA FROM THE HARMONY PROJECT".
Click here to open the abstract >
Click here to watch the video interview with Luca Guarnera about his ASH2023 HARMONY APL presentation >
This is the link to the congress website >
The HARMONY Alliance would like to thank the Società Italiana di Ematologia Sperimentale for this opportunity.
Receive the latest news. Click here to subscribe!
Public-private partnership for Big Data in Hematology
HARMONY and HARMONY PLUS are funded through the Innovative Medicines Initiative (IMI), Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients. Funding is received from the IMI 2 Joint Undertaking and is listed under grant agreement for HARMONY No. 116026 and grant agreement for HARMONY PLUS No. 945406. This Joint Undertaking receives support from the European Union’s Horizon 2020 Research and Innovation Programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA).
HARMONY Coordination Office
Institute of Biomedical Research of
Salamanca (IBSAL)
Salamanca, Spain
HARMONY Communications
European Hematology Association (EHA)
The Hague, The Netherlands
